{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:23:06Z","timestamp":1792891386270,"version":"4.5.0"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Using national pharmacy claims data for 2014\u20132020, 843\u2005329 persons were treated for hepatitis C at least once. The proportion treated increased annually among persons aged &amp;lt;40 years, insured by Medicaid, and treated by primary care providers. Monitoring hepatitis C treatment is essential to identify barriers to treatment access.<\/jats:p>","DOI":"10.1093\/cid\/ciac139","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:51Z","timestamp":1644883251000},"page":"1078-1080","source":"Crossref","is-referenced-by-count":32,"title":["Characteristics of Persons Treated for Hepatitis C Using National Pharmacy Claims Data, United States, 2014\u20132020"],"prefix":"10.1093","volume":"75","author":[{"given":"Eyasu H","family":"Teshale","sequence":"first","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Roberts","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Gupta","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Jiles","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"key":"2022092921010528000_CIT0001","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.30297","article-title":"Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016.","volume":"69","author":"Hofmeister","year":"2019","journal-title":"Hepatology"},{"key":"2022092921010528000_CIT0002","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(18)32111-1","article-title":"Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.","volume":"393","author":"Carrat","year":"2019","journal-title":"Lancet"},{"key":"2022092921010528000_CIT0003","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.drugpo.2015.05.006","article-title":"Hepatitis C transmission and treatment as prevention\u2014the role of the injecting network.","volume":"26","author":"Hellard","year":"2015","journal-title":"Int J Drug Policy"},{"key":"2022092921010528000_CIT0004","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/hep.31060","article-title":"AASLD-IDSA Hepatitis C Guidance Panel. Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.","volume":"71","author":"Ghany","year":"2020","journal-title":"Hepatology"},{"key":"2022092921010528000_CIT0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/MCG.0000000000001344","article-title":"Low uptake of direct-acting antiviral therapy among hepatitis C patients with advanced liver disease and access to care, 2014-2017.","volume":"55","author":"Spradling","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"2022092921010528000_CIT0006","article-title":"Office of Public and Intergovernmental Affairs. VA on path to cure 100,000 veterans of hepatitis C","author":"US Department of Veteran Affairs"},{"key":"2022092921010528000_CIT0007","doi-asserted-by":"publisher","volume-title":"A National Strategy for the Elimination of Hepatitis B and Phase Two Report","year":"2017","DOI":"10.17226\/24731"},{"key":"2022092921010528000_CIT0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults\u2014United States, 2020.","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"2022092921010528000_CIT0009","article-title":"2019 Viral Hepatitis Surveillance Report","author":"Centers for Disease Control and Prevention."},{"key":"2022092921010528000_CIT0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/M17-0118","article-title":"Expansion of treatment for hepatitis C virus infection by task shifting to community-based nonspecialist providers: a non-randomized clinical trial.","volume":"167","author":"Kattakuzhy","year":"2017","journal-title":"Ann Intern Med"},{"key":"2022092921010528000_CIT0011","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugpo.2018.08.013","article-title":"Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: the SIMPLIFY study.","volume":"62","author":"Cunningham","year":"2018","journal-title":"Int J Drug Policy"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac139\/43694606\/ciac139.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/6\/1078\/46205158\/ciac139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/6\/1078\/46205158\/ciac139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T17:06:51Z","timestamp":1664471211000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/75\/6\/1078\/6529537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":11,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,2,16]]},"published-print":{"date-parts":[[2022,9,29]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac139","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,15]]},"published":{"date-parts":[[2022,2,16]]}}}